The Effects of Transcutaneous Occipital Nerve Stimulation and Instrument-Assisted Soft Tissue Mobilization on Patients With Chronic Migraine
NCT ID: NCT05372796
Last Updated: 2022-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2021-09-01
2022-02-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Cervical Kinesio Taping in Migraine
NCT06203678
The Effect of Connective Tissue Massage in Patients With Migraine
NCT04171362
THE EFFECTS OF KINESIO®TAPING IN PATIENTS WITH MIGRAINE
NCT04185714
Efficacy of Manual Therapy for the Treatment of Migraine.
NCT03555214
Trigger Point Dry Needling for Chronic Tension-Type Headache
NCT03500861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
participants were given home exercise (once a day for 5 weeks)
home exercise
home exercise
IASTM (instrument-assisted soft tissue mobilization)
IASTM was applied to the patients (M. Sternocleidomastoideus, M. Trapezius, M. Paraspinales and M. Levator Scapula) in the IASTM group twice a week for 5 weeks.
IASTM
instrument-assisted soft tissue mobilization
OTES (Occipital Transcutenous Electric Stimulation)
Participants in the OTES group were treated with a Chattanooga direct Tens device (DJO UK Ltd, Guildford Surrey, United Kingdom) 3 times a week for 5 weeks. Four self-adhesive 40\*40 mm sized electrodes were attached to the occipital region of the patients bilaterally, covering the occipital nerves. The current intensity was adjusted according to the patient. The current intensity started from 0 mA and the current intensity was increased one by one every 30 seconds, the patient was allowed to tolerate the current by giving current without muscle twitching or harmful stimulation. The current frequency was determined as 2/100 Hz. Square waves at 2 Hz were applied for 3 seconds followed by an automatic shift to 100 Hz for another 3 seconds.
Chattanooga direct Tens device (DJO UK Ltd, Guildford Surrey, United Kingdom)
OTES (Occipital Transcutenous Electric Stimulation)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IASTM
instrument-assisted soft tissue mobilization
home exercise
home exercise
Chattanooga direct Tens device (DJO UK Ltd, Guildford Surrey, United Kingdom)
OTES (Occipital Transcutenous Electric Stimulation)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* International Classification of headache disorders, Third Edition (beta), using the criteria to be diagnosed with migraine without aura,
* migraine with a history of being at least an annual,
* VAS neck pain to be on Level 4,
* the hit-6 score is greater than 56
Exclusion Criteria
* using a pacemaker,
* being an epileptic or severely psychiatric patient,
* conducting a surgical operation from the neck region,
* cervical disc degeneration or prolapse, the presence of different diagnoses of headaches
20 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KTO Karatay University
OTHER
Emine Atıcı
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emine Atıcı
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emine Atıcı
Tuzla, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.